Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals

By afschroeder • November 23, 2025

Matthews R, Armstrong AW, Augustin M, Baker C, Carrascosa JM, Kirby B, Langley R, McBride S, Reich A, Romiti R, Sampogna F, Warren RB. Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals. Dermatol Ther (Heidelb). 2025 Nov 22. doi: 10.1007/s13555-025-01573-1. Epub ahead of print. PMID: 41273665.

Tags: CLCI, clinical management, Cross-section, Dermatology, Life, patient experience, psoriasis, Publications

Photosensitive symmetric papules of the nasal alae

Peng DS, Dong E, Seivright J, Gates G, Nguyen MO. Photosensitive symmetric papules of the nasal alae. JAAD Case Rep. 2026 Jan 21;70:253-255. doi: 10.1016/j.jdcr.2026.01.017.[...]

International development of Investigator Global Assessment scores for pemphigus

Murrell DF, Boucher D, Daneshpazhooh M, Mahmoudi H, Kianfar N, Dasdar S, Yale M, Wilson A, Bilgic A, Uzun S, Chandran NS, Patsatsi A, Drenovska[...]

Envudeucitinib, a Potent, Next-Generation, Allosteric Inhibitor of TYK2: A Narrative Review

Armstrong AW, Krueger JG, Strober BE, Stein Gold LF, Desai SR, Muscianisi E, Klyachkin Y, Ucpinar S, Tilley MK, Blauvelt A. Envudeucitinib, a Potent, Next-Generation,[...]